# Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study

> **NCT02213419** · PHASE1 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Pancreatic Mucinous-Cystic Neoplasm

## Interventions

- **DRUG:** Endoscopic ultrasonography-guided double ethanol lavage

## Key facts

- **NCT ID:** NCT02213419
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02213419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02213419, "Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02213419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*